Core One Labs Inc. (OTCMKTS:CLABF) has announced the filing of a Trademark Application with WIPO Madrid in addition to the company’s CannaStrips filings. The Applications intends to trademark “CBDSTRIPS in Germany, Spain, as well as the UK.
Core One Labs plotting expansion to Europe
This filing of additional Trademarks by the company intends to protect Core One Labs’ future product brands across Europe. This is part of the company’s expected expansion into the European marketplace. The countries the company identified in the application appeared to be the most viable countries where they will distribute the COOL products.
Currently, the company can’t distribute its products outside the state of California. But the protection of the company’s technology and brands across the world indicates that there is a possibility of expanding to different places. The company can achieve this through a licensing agreement or joint ventures. Core One Labs has future global expectations for its COOL products as well as for the CannaStrip brand.
Brad Eckenweiler, the CEO of Core One Labs, indicated that the company was establishing foundations globally that will benefit the company in the future. Brad added that it is important to build for the future and identify opportunities as well as innovations that support Core One Labs’ mission and business model.
Core One Labs produces CannaStrips using the latest tech
The company uses the latest technology in its production and packaging facility in California. It produces infused strips that offer a better delivery option compared to other options. Similarly, the strips have premium bioavailability of cannabis ingredients, with some even having co-active constituents such as vitamins, nutraceuticals, and peptides.
CannaStriups are oral strips that offer effective buccal mucosa delivery by disrupting the barrier formed by saliva coating the mucosa membrane. This allows the CBD ingredients encapsulated and nanoparticulated in the strips to pass through multiple mucosal membranes into the bloodstream. Once in the system, encapsulation prevents the liver from filtering the material out of the bloodstream as foreign material. This, therefore, increases bioavailability, thus increasing the effective time of a single dose.
Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada
Post Views: 115 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...
Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets
Post Views: 146 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...
1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada
Post Views: 134 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...
Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe
Post Views: 63 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...
Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA
Post Views: 198 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...
cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA
Post Views: 310 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...